MDM2 and HIF1alpha expression levels in different histologic subtypes of malignant pleural mesothelioma

Correlation with pathological and clinical data

Giulia Pasello, Loredana Urso, Manlio Mencoboni, Federica Grosso, Giovanni Luca Ceresoli, Francesca Lunardi, Stefania Edith Vuljan, Roberta Bertorelle, Valeria Sacchetto, Vincenzo Ciminale, Federico Rea, Adolfo Favaretto, PierFranco Conte, Fiorella Calabrese

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Malignant pleural mesothelioma (MPM) is an aggressive tumor with poor prognosis and limited treatment options. Sarcomatoid/biphasic mesotheliomas are characterized by more aggressive behaviour and a poorer prognosis compared with the epithelioid subtype. To date prognostic and tailored therapeutic biomarkers are lacking. The present study analyzed the expression levels of MDM2 and HIF1alpha in different histologic subtypes from chemonaive MPM patients. Diagnostic biopsies of MPM patients from four Italian cancer centers were centrally collected and analyzed. MDM2 and HIF1alpha expression levels were investigated through immunohistochemistry and RT-qPCR. Pathological assessment of necrosis, inflammation and proliferation index was also performed. Molecular markers, pathological features and clinical characteristics were correlated to overall survival (OS) and progression free survival (PFS). Sixty MPM patients were included in the study (32 epithelioid and 28 non-epithelioid). Higher levels of MDM2 (p <0.001), HIF1alpha (p = 0.013), necrosis (p = 0.013) and proliferation index (p <0.001) were seen mainly in sarcomatoid/biphasic subtypes. Higher levels of inflammation were significantly associated with epithelioid subtype (p = 0.044). MDM2 expression levels were correlated with HIF1alpha levels (p = 0.0001), necrosis (p = 0.008) and proliferation index (p = 0.009). Univariate analysis showed a significant correlation of non-epithelioid histology (p = 0.04), high levels of necrosis (p = 0.037) and proliferation index (p = 0.0002) with shorter PFS. Sarcomatoid/biphasic and epithelioid mesotheliomas showed different MDM2 and HIF1alpha expression levels and were characterized by different levels of necrosis, proliferation and inflammation. Further studies are warranted to confirm a prognostic and predictive role of such markers and features.

Original languageEnglish
Pages (from-to)42053-42066
Number of pages14
JournalOncotarget
Volume6
Issue number39
DOIs
Publication statusPublished - 2015

Fingerprint

Necrosis
Mesothelioma
Inflammation
Disease-Free Survival
Neoplasms
Histology
Biomarkers
Immunohistochemistry
Malignant Mesothelioma
Biopsy
Survival
Therapeutics

Keywords

  • HIF1alpha
  • Inflammation
  • MDM2
  • Mesothelioma
  • Necrosis

ASJC Scopus subject areas

  • Oncology

Cite this

MDM2 and HIF1alpha expression levels in different histologic subtypes of malignant pleural mesothelioma : Correlation with pathological and clinical data. / Pasello, Giulia; Urso, Loredana; Mencoboni, Manlio; Grosso, Federica; Ceresoli, Giovanni Luca; Lunardi, Francesca; Vuljan, Stefania Edith; Bertorelle, Roberta; Sacchetto, Valeria; Ciminale, Vincenzo; Rea, Federico; Favaretto, Adolfo; Conte, PierFranco; Calabrese, Fiorella.

In: Oncotarget, Vol. 6, No. 39, 2015, p. 42053-42066.

Research output: Contribution to journalArticle

Pasello, G, Urso, L, Mencoboni, M, Grosso, F, Ceresoli, GL, Lunardi, F, Vuljan, SE, Bertorelle, R, Sacchetto, V, Ciminale, V, Rea, F, Favaretto, A, Conte, P & Calabrese, F 2015, 'MDM2 and HIF1alpha expression levels in different histologic subtypes of malignant pleural mesothelioma: Correlation with pathological and clinical data', Oncotarget, vol. 6, no. 39, pp. 42053-42066. https://doi.org/10.18632/oncotarget.5974
Pasello, Giulia ; Urso, Loredana ; Mencoboni, Manlio ; Grosso, Federica ; Ceresoli, Giovanni Luca ; Lunardi, Francesca ; Vuljan, Stefania Edith ; Bertorelle, Roberta ; Sacchetto, Valeria ; Ciminale, Vincenzo ; Rea, Federico ; Favaretto, Adolfo ; Conte, PierFranco ; Calabrese, Fiorella. / MDM2 and HIF1alpha expression levels in different histologic subtypes of malignant pleural mesothelioma : Correlation with pathological and clinical data. In: Oncotarget. 2015 ; Vol. 6, No. 39. pp. 42053-42066.
@article{3bbe9e30800540e6be3bb20ee1554358,
title = "MDM2 and HIF1alpha expression levels in different histologic subtypes of malignant pleural mesothelioma: Correlation with pathological and clinical data",
abstract = "Malignant pleural mesothelioma (MPM) is an aggressive tumor with poor prognosis and limited treatment options. Sarcomatoid/biphasic mesotheliomas are characterized by more aggressive behaviour and a poorer prognosis compared with the epithelioid subtype. To date prognostic and tailored therapeutic biomarkers are lacking. The present study analyzed the expression levels of MDM2 and HIF1alpha in different histologic subtypes from chemonaive MPM patients. Diagnostic biopsies of MPM patients from four Italian cancer centers were centrally collected and analyzed. MDM2 and HIF1alpha expression levels were investigated through immunohistochemistry and RT-qPCR. Pathological assessment of necrosis, inflammation and proliferation index was also performed. Molecular markers, pathological features and clinical characteristics were correlated to overall survival (OS) and progression free survival (PFS). Sixty MPM patients were included in the study (32 epithelioid and 28 non-epithelioid). Higher levels of MDM2 (p <0.001), HIF1alpha (p = 0.013), necrosis (p = 0.013) and proliferation index (p <0.001) were seen mainly in sarcomatoid/biphasic subtypes. Higher levels of inflammation were significantly associated with epithelioid subtype (p = 0.044). MDM2 expression levels were correlated with HIF1alpha levels (p = 0.0001), necrosis (p = 0.008) and proliferation index (p = 0.009). Univariate analysis showed a significant correlation of non-epithelioid histology (p = 0.04), high levels of necrosis (p = 0.037) and proliferation index (p = 0.0002) with shorter PFS. Sarcomatoid/biphasic and epithelioid mesotheliomas showed different MDM2 and HIF1alpha expression levels and were characterized by different levels of necrosis, proliferation and inflammation. Further studies are warranted to confirm a prognostic and predictive role of such markers and features.",
keywords = "HIF1alpha, Inflammation, MDM2, Mesothelioma, Necrosis",
author = "Giulia Pasello and Loredana Urso and Manlio Mencoboni and Federica Grosso and Ceresoli, {Giovanni Luca} and Francesca Lunardi and Vuljan, {Stefania Edith} and Roberta Bertorelle and Valeria Sacchetto and Vincenzo Ciminale and Federico Rea and Adolfo Favaretto and PierFranco Conte and Fiorella Calabrese",
year = "2015",
doi = "10.18632/oncotarget.5974",
language = "English",
volume = "6",
pages = "42053--42066",
journal = "Oncotarget",
issn = "1949-2553",
publisher = "Impact Journals LLC",
number = "39",

}

TY - JOUR

T1 - MDM2 and HIF1alpha expression levels in different histologic subtypes of malignant pleural mesothelioma

T2 - Correlation with pathological and clinical data

AU - Pasello, Giulia

AU - Urso, Loredana

AU - Mencoboni, Manlio

AU - Grosso, Federica

AU - Ceresoli, Giovanni Luca

AU - Lunardi, Francesca

AU - Vuljan, Stefania Edith

AU - Bertorelle, Roberta

AU - Sacchetto, Valeria

AU - Ciminale, Vincenzo

AU - Rea, Federico

AU - Favaretto, Adolfo

AU - Conte, PierFranco

AU - Calabrese, Fiorella

PY - 2015

Y1 - 2015

N2 - Malignant pleural mesothelioma (MPM) is an aggressive tumor with poor prognosis and limited treatment options. Sarcomatoid/biphasic mesotheliomas are characterized by more aggressive behaviour and a poorer prognosis compared with the epithelioid subtype. To date prognostic and tailored therapeutic biomarkers are lacking. The present study analyzed the expression levels of MDM2 and HIF1alpha in different histologic subtypes from chemonaive MPM patients. Diagnostic biopsies of MPM patients from four Italian cancer centers were centrally collected and analyzed. MDM2 and HIF1alpha expression levels were investigated through immunohistochemistry and RT-qPCR. Pathological assessment of necrosis, inflammation and proliferation index was also performed. Molecular markers, pathological features and clinical characteristics were correlated to overall survival (OS) and progression free survival (PFS). Sixty MPM patients were included in the study (32 epithelioid and 28 non-epithelioid). Higher levels of MDM2 (p <0.001), HIF1alpha (p = 0.013), necrosis (p = 0.013) and proliferation index (p <0.001) were seen mainly in sarcomatoid/biphasic subtypes. Higher levels of inflammation were significantly associated with epithelioid subtype (p = 0.044). MDM2 expression levels were correlated with HIF1alpha levels (p = 0.0001), necrosis (p = 0.008) and proliferation index (p = 0.009). Univariate analysis showed a significant correlation of non-epithelioid histology (p = 0.04), high levels of necrosis (p = 0.037) and proliferation index (p = 0.0002) with shorter PFS. Sarcomatoid/biphasic and epithelioid mesotheliomas showed different MDM2 and HIF1alpha expression levels and were characterized by different levels of necrosis, proliferation and inflammation. Further studies are warranted to confirm a prognostic and predictive role of such markers and features.

AB - Malignant pleural mesothelioma (MPM) is an aggressive tumor with poor prognosis and limited treatment options. Sarcomatoid/biphasic mesotheliomas are characterized by more aggressive behaviour and a poorer prognosis compared with the epithelioid subtype. To date prognostic and tailored therapeutic biomarkers are lacking. The present study analyzed the expression levels of MDM2 and HIF1alpha in different histologic subtypes from chemonaive MPM patients. Diagnostic biopsies of MPM patients from four Italian cancer centers were centrally collected and analyzed. MDM2 and HIF1alpha expression levels were investigated through immunohistochemistry and RT-qPCR. Pathological assessment of necrosis, inflammation and proliferation index was also performed. Molecular markers, pathological features and clinical characteristics were correlated to overall survival (OS) and progression free survival (PFS). Sixty MPM patients were included in the study (32 epithelioid and 28 non-epithelioid). Higher levels of MDM2 (p <0.001), HIF1alpha (p = 0.013), necrosis (p = 0.013) and proliferation index (p <0.001) were seen mainly in sarcomatoid/biphasic subtypes. Higher levels of inflammation were significantly associated with epithelioid subtype (p = 0.044). MDM2 expression levels were correlated with HIF1alpha levels (p = 0.0001), necrosis (p = 0.008) and proliferation index (p = 0.009). Univariate analysis showed a significant correlation of non-epithelioid histology (p = 0.04), high levels of necrosis (p = 0.037) and proliferation index (p = 0.0002) with shorter PFS. Sarcomatoid/biphasic and epithelioid mesotheliomas showed different MDM2 and HIF1alpha expression levels and were characterized by different levels of necrosis, proliferation and inflammation. Further studies are warranted to confirm a prognostic and predictive role of such markers and features.

KW - HIF1alpha

KW - Inflammation

KW - MDM2

KW - Mesothelioma

KW - Necrosis

UR - http://www.scopus.com/inward/record.url?scp=84951823898&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84951823898&partnerID=8YFLogxK

U2 - 10.18632/oncotarget.5974

DO - 10.18632/oncotarget.5974

M3 - Article

VL - 6

SP - 42053

EP - 42066

JO - Oncotarget

JF - Oncotarget

SN - 1949-2553

IS - 39

ER -